CREATOR: Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05358158
Collaborator
Aarhus University Hospital (Other)
94
2
20

Study Details

Study Description

Brief Summary

Chest drain is used routinely after lung surgery. Despite preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal, these are either retrospective or mainly concerning benign disease.

Hypothesis: Participants treated without post-operative chest tube after thoracoscopic wedge resection have less pain, reduced opioid usage without increasing postoperative complications than participants treated with standard post-operative chest tube, and could possibly be discharged earlier.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intraoperative air leak test
  • Procedure: Intraoperative chest drain removal
  • Procedure: Standard chest drain placement
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
94 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy of Avoiding Chest Drain After Video-assisted Thoracoscopic Surgery Wedge Resection
Anticipated Study Start Date :
May 2, 2022
Anticipated Primary Completion Date :
May 2, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Drain-free group

Participants undergoing video-assisted thoracoscopic wedge resection with a positive intraoperative sealing test are treated with intraoperative chest tube removal.

Procedure: Intraoperative air leak test
A standard 28 Fr chest drain is inserted through the anterior port hole with all port holes closed. With the tip of the chest tube below water, the pleura is emptied from air during continuous ventilation of the lungs. An air leak after 5 minutes of ventilation indicates a negative sealing test, whereas a cessation of air leak within 5 minutes indicates a positive sealing test.

Procedure: Intraoperative chest drain removal
Chest drain is removed intraoperatively.

Active Comparator: Chest drain group

Participants undergoing video-assisted thoracoscopic wedge resection with a positive intraoperative sealing test are treated with a standard postoperative chest tube.

Procedure: Intraoperative air leak test
A standard 28 Fr chest drain is inserted through the anterior port hole with all port holes closed. With the tip of the chest tube below water, the pleura is emptied from air during continuous ventilation of the lungs. An air leak after 5 minutes of ventilation indicates a negative sealing test, whereas a cessation of air leak within 5 minutes indicates a positive sealing test.

Procedure: Standard chest drain placement
Chest drain is left in pleura.

Outcome Measures

Primary Outcome Measures

  1. Acute Pain [Up to postoperative day 1]

    Postoperative pain assessed in three different situations (at rest, arms lifted and during cough) by questionnaire at 3 and 6 hours after surgery, and on the morning of postoperative day 1 at 8 a.m

  2. Rescue analgesics [Up to postoperative day 1]

    The amount of rescue analgesics given assessed as cumulative amount of morphine during the first 24 hours after surgery milligram equivalents (MME) as defined by pro.medicine.dk hosted by the Danish Association of the Pharmaceutical Industry

Secondary Outcome Measures

  1. Pneumothorax [Up to postoperative 2 weeks]

    Number and size of pneumothorax at 6 hours after surgery in the drain-free group, 2 hours after drain removal in the drain group, and postoperative 2-week for both

  2. Complications [Up to postoperative day 30]

    Surgical and medical complications including mortality

  3. Chest drain reinsertion [Up to postoperative day 30]

    Number and reasons of chest drain reinsertion

  4. Length of stay [Through post-operative discharge, an average of 2 days]

    Days in hospital after index surgery

  5. Time to fulfilled discharge criteria [Through post-operative discharge, an average of 2 days]

    Days to meet discharge criteria but stay in hospital

  6. Readmission [Through post-operative admission, an average of 7 days]

    Number and reasons of readmissions

  7. Quality of recovery after surgery [Up to postoperative day 1]

    Evaluate patients' quality of life by questionnaire before surgery, at the first day after surgery

  8. Standard analgesics given [Up to postoperative 2 weeks]

    Number of patients who did not receive planned postoperative analgesics according to the standards at their institution

  9. Persistent pain [Up to postoperative day 6]

    Postoperative pain assessed in three different situations (at rest, arms lifted and during cough) by questionnaire from postoperative day 2 to 6.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥18 years.

  • Patients referred for elective three port video-assisted thoracoscopic surgery wedge resection of the lung for suspected or confirmed malignant nodules.

  • first second forced expiratory volume ≥60% of expected.

  • No increased bleeding risk (e.g. preoperative international normalized ratio >2, overdue discontinuation of anticoagulants according to guidelines by the Danish Society for Thrombosis and Haemostasis, known coagulopathy).

  • Not scheduled for frozen section pathology of wedge resection and subsequent lobectomy.

  • Able and willing to give informed consent.

Exclusion Criteria:
  • Increased risk of post-operative air leak assessed perioperatively by the surgeon (e.g. severe adhesions, bullous/emphysematous lung tissue, defects of the visceral pleura due to iatrogenic or other reasons, suturing in the lung tissue, deep lung resection).

  • Increased risk of post-operative bleeding assessed perioperatively by the surgeon (e.g. intraoperative bleeding or oozing).

  • Air leak during intraoperative air leak test.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Rigshospitalet, Denmark
  • Aarhus University Hospital

Investigators

  • Study Chair: René H Petersen, MD, PhD, Rigshospitalet, Denmark
  • Study Director: Thomas D Christensen, MD, PhD, Aarhus University Hospital
  • Principal Investigator: Bo L Holbek, MD, PhD, Rigshospitalet, Denmark
  • Principal Investigator: Morten Bendixen, MD, PhD, Aarhus University Hospital
  • Principal Investigator: Jonas J Rasmussen, MD, Aarhus University Hospital
  • Principal Investigator: Henrik Kehlet, MD, PhD, Rigshospitalet, Denmark
  • Principal Investigator: Henrik J Hansen, MD, Rigshospitalet, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lin Huang, Department of cardiothoracic surgery, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT05358158
Other Study ID Numbers:
  • H-21012837
First Posted:
May 3, 2022
Last Update Posted:
May 9, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 9, 2022